Browse by author
Lookup NU author(s): Professor John IsaacsORCiD
Earlier diagnosis and treatment, plus biological therapies, have transformed the outlook for many patients with rheumatoid arthritis. In the future, new biomarkers for diagnosis, prognosis and therapeutic response will further improve outcomes. Additionally, preclinical diagnosis and tolerogenic therapies could provide sustained remission for some individuals, although ethical and societal challenges must also be addressed before rheumatoid arthritis becomes 'yesterday's disease'.
Author(s): Isaacs JD
Publication type: Review
Publication status: Published
Journal: Nature Reviews Immunology
Year: 2010
Volume: 10
Issue: 8
Pages: 605-611
Print publication date: 01/08/2010
ISSN (print): 1474-1733
ISSN (electronic): 1474-1741
URL: http://dx.doi.org/10.1038/nri28041038
DOI: 10.1038/nri2804